The authors reported that thiazolidinediones might decrease ALT levels and improve histological parameters and that pioglitazone might reverse fibrosis in NASH; however, this latter effect represents the most important point of interest. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.